China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
This article was originally published in The Pink Sheet Daily
Executive Summary
Small companies struggle to advance in new, stricter regulatory environment.
You may also be interested in...
Anti-Corruption Regs In China Should Be Warning Sign For Companies
The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, according to Australia medical device lobbyist Anne Trimmer
WuXi PharmaTech And Covance To Partner On Preclinical Testing In China
BEIJING - WuXi PharmaTech, China's leading contract research organization, and Princeton, N.J.-based Covance are set to create a joint venture to provide preclinical drug testing services in China
WuXi PharmaTech Set For Sales Synergy With U.S. Subsidiary AppTec
Contract research firm draws on AppTec's biotech expertise to expand operations.